NEW YORK and SALT LAKE CITY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will report its fourth quarter and full year fiscal 2022 financial results on Monday, October 31, 2022, before market open.
RNS Number : 7880D Renalytix PLC 24 October 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31 NEW YORK and SALT LAKE CITY , October 24, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost economics for Medicare population NEW YORK and SALT LAKE CITY, Oct.
RNS Number : 0165D Renalytix PLC 17 October 2022 KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology Four presentations, including first clinical utility findings from multi-year real world evidence results from a major
LONDON and SALT LAKE CITY, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that Ann Berman, non-executive director and chair of the audit and nomination committees, has resigned as a director of the Company for personal reasons effective immediately. Ms.
RNS Number : 9534Z Renalytix PLC 20 September 2022 Renalytix plc ("Renalytix" or the "Company") Renalytix Announces Change to Board of Directors LONDON and SALT LAKE CITY , 20 September 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that Ann Berman , non-executive director
RNS Number : 0215Z Renalytix PLC 12 September 2022 Renalytix plc ("Renalytix" or the "Company") Issue of shares NEW YORK and SALT LAKE CITY , 12 September, 2022 - Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) announces that under the Company's Employee Share Purchase Plan (the "ESPP"),
NEW YORK and SALT LAKE CITY, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the company will participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference to be held September 12-14, 2022.
RNS Number : 6200Y Renalytix PLC 08 September 2022 Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference NEW YORK, NY and SALT LAKE CITY, UT ̶ September 8, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the company will participate in a
RNS Number : 3072W Renalytix PLC 17 August 2022 This contains inside information Renalytix plc ("Renalytix" or the "Company") Business update NEW YORK, NY and SALT LAKE CITY, UT August 17, 2022 (GLOBE NEWSWIRE) - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) provides the following business
